Drug Pipeline

Lumateperone Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-03 NCT07623135 Lumateperone for Late-Life Depression Phase 3 Not Yet Recruiting
Active Studies by Phase
Phase 4
2
Phase 3
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06174116 Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With… Schizophrenia Recruiting
NCT07369115 Neurocircuitry Mechanisms and Efficacy of Lumateperone as Adjunctive Therapy for Major… Major Depressive Diorder Not Yet Recruiting
Phase 3
NCT07623135 Lumateperone for Late-Life Depression Treatment Resistant Depression (TRD) Not Yet Recruiting
Sponsors Running Lumateperone Trials
University of Massachusetts, Worcester (1) University of Texas at Austin (1) Eric Lenze (1)
Disease Areas
Schizophrenia (1) Depression (1)
Get alerts when Lumateperone trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free